TCE2 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Celldex Therapeutics Inc

Watchlist Manager

Watchlist

Price: 34.26 EUR -1.75% Market Closed

Market Cap: €2.3B

	Celldex Therapeutics Inc F:TCE2	US
S	Standard Chartered PLC SWB:STD	UK
	Intesa Sanpaolo SpA F:IES	IT
I	ITV PLC SWB:IJ7	UK
	Baidu Inc F:B1CB	CN
S	State Street Corp XMUN:ZYA	US
I	Intuitive Surgical Inc XMUN:IUI1	US
E	Element Solutions Inc F:PLQ	US

Profitability Summary

Celldex Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-206 220%

Negative 3Y Average Operating Margin

-24 324%

Declining Operating Margin

-3 720% > -206 220%

Negative Net Margin

-190 221%

Negative 3Y Average Net Margin

-22 255%

Declining Net Margin

-3 470% > -190 221%

Negative Free Cash Flow Margin

-153 231%

Negative 3Y Average Free Cash Flow Margin

-18 074%

Declining Free Cash Flow Margin

-3 506% > -153 231%

Negative ROE

-44%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-423%

Declining ROIC

-267% > -592%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.